George Retsch-Bogart MD

Emeritus Professor of Pediatrics

450 MacNider Hall, CB 7217333 S. Columbia St.Chapel Hill, NC 27599
Phone+1 919-966-1055
Fax+1 919-966-6179

Dr. Retsch-Bogart is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Retsch-Bogart's full profile Already have an account?

Summary

Dr. George Retsch-Bogart is a pediatric pulmonologist based in Chapel Hill, NC. He completed his pediatrics residency at the University of Minnesota and a fellowship in pediatric pulmonology at the University of North Carolina Hospitals. He has been a member of the faculty at the University of North Carolina at Chapel Hill School of Medicine since 1989 and Emeritus Professor since July 2024. His expertise includes cystic fibrosis, clinical research, clinical research network development and QI for clinical research, pseudomonal lung infections, and anti-bacterial agents. Dr. Retsch-Bogart has contributed to numerous clinical trials and published research, notably on cystic fibrosis treatment efficacy and safety. His work has been cited numerous times, highlighting his contributions to advancements in the field. Additionally, he has received recognition by the Cystic Fibrosis Foundation in the Richard C. Talamo Distinguished Clinical Achievement Award and membership in the American Pediatric Society.

Education & Training

University of North Carolina HospitalsFellowship, Pediatric Pulmonology, 1986 - 1989
University of MinnesotaResidency, Pediatrics, 1978 - 1981
University of Cincinnati College of MedicineClass of 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NC State Medical License 1986 - 2024
MN State Medical License 1980 - 1987
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

American Pediatric Society 2018
Regional Top Doctor Castle Connolly, 2014
Fellow of American Academy of Pediatrics American Academy of Pediatrics

Clinical Trials

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis
COMPLETED
PHASE2
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
COMPLETED
PHASE2
Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
COMPLETED
PHASE2

Publications & Presentations

PubMed

3 citations
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least OneAllele: A 192-Week, Phase 3, Open-Label Ext...
Claire Wainwright, Susanna A McColley, Paul McNally, Michael Powers, Felix Ratjen
American Journal of Respiratory and Critical Care Medicine. 2025-10-01
Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection.
Brandie D Wagner, Edith T Zemanick, Scott D Sagel, Charles E Robertson, Mark J Stevens
BMC Microbiology. 2023-10-27
25 citations
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.
Nicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, Scott H Donaldson, Isabelle Fajac
The Lancet. Respiratory Medicine. 2023-10-01

Grant Support

Phase III Placebo Controlled--Tobramycin Inhalation In Cystic Fibrosis PatientsNational Center For Research Resources1997
Aerosolized Nucleotides (Atp/Utp) As New Therapy For CF Lung DiseaseNational Center For Research Resources1996–1997